Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Profiling T Cell Receptor Repertoires in Phase I/II Clinical Trials of Donor Treg Infusion for the Treatment of Chronic Graft-Versus-Host Disease

Blood (2018) 132 (Supplement 1): 4563.

https://doi.org/10.1182/blood-2018-99-111866

Published: 2018

Journal Articles

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

Juergen Foell, MD, Johannes Schulte, Anja Troeger, MD, Beatrix Pfirstinger, MD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Petra Hoffmann, PhD, Charalampos Aslanidis, PhD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD

Blood (2018) 132 (Supplement 1): 3455.

https://doi.org/10.1182/blood-2018-99-114695

Published: 2018

Journal Articles

Assessment of Calcineurin Inhibitor-Associated Neurotoxicity in Patients with Sickle Cell Disease Receiving a Matched Sibling Donor or T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Katharina Kleinschmidt, MD PhD, Juergen Foell, MD, Johannes Schulte, Beatrix Pfirstinger, MD, Anja Troeger, MD, Charalampos Aslanidis, PhD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD

Blood (2018) 132 (Supplement 1): 2088.

https://doi.org/10.1182/blood-2018-99-115988

Published: 2018

Journal Articles

Comparable Outcome of CD3+-/CD19+ Depleted Haploidentical with Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Advanced Stage Sickle Cell Disease: Result of a Pilot Study

Selim Corbacioglu, MD PhD, Juergen Foell, MD, Daniel Wolff, MD, Ernst Holler, MD, Beatrix Pfirstinger, MD, Klaus Thorsten Rehe, MD, Petra Hoffmann, PhD, Matthias Edinger, MD, Anja Troeger, MD, Svatava Srutkova, MD

Blood (2017) 130 (Supplement 1): 4594.

https://doi.org/10.1182/blood.V130.Suppl_1.4594.4594

Published: 2017

Journal Articles

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Rüdiger Hehlmann, MD, Michael Lauseker, PhD, Susanne Saussele, MD, Markus Pfirrmann, Stefan W. Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, Christoph Nerl, MD, Alois Gratwohl, MD, Gabriela M. Baerlocher, Dominik Heim, MD, Tim Henrik Bruemmendorf, Alice Fabarius, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martin C. Müller, MD, Sabine Jeromin, PhD, Ulrike Proetel, PhD, Katharina Kohlbrenner, PhD, Astghik Voskanyan, PhD, Sébastien Rinaldetti, Wolfgang Seifarth, PhD, Birgit Spiess, Leopold Balleisen, MD, Maria E Goebeler, MD, Mathias Hänel, MD, Anthony D. Ho, MD, J Dengler, C Falge, Lothar Kanz, MD, Claus-Henning Köhne, MD, PhD, Andreas Burchert, MD, Michael Kneba, MD PhD, Frank Stegelmann, MD, C Köhne, Hans-Walter Lindemann, C Waller, Michael Pfreundschuh, MD, Karsten Spiekermann, Wolfgang E Berdel, MD, L Müller, Matthias Edinger, MD, Jiri Mayer, Prof, MD SCs, Dietrich W Beelen, MD PhD, Martin Bentz, MD, Hartmut Link, MDPhD, Bernd Hertenstein, MD, R Fuchs, Martin Wernli, MD, F Schlegel, Rudolph Schlag, M de Wit, Lorenz Trümper, MD, H Hebarth, M Hahn, Jörg Thomalla, MD, Christof Scheid, MD, Philippe Schafhausen, MD, Walter Verbeek, MD, Michael J. Eckart, MD, Winfried Gassmann, MD PhD, Antonio Pezzutto, MD, Michael Schenk, Peter Brossart, MD, Thomas Geer, MD, Stephan Bildat, E Schäfer, Andreas Hochhaus, MD, Joerg Hasford

Blood (2017) 130 (Supplement 1): 897.

https://doi.org/10.1182/blood.V130.Suppl_1.897.897

Published: 2017

Journal Articles

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Christian T. Dietz, PhD, Alice Charlotte Fabarius, PhD, Michael Lauseker, PhD, Susanne Saussele, Lida Kalmanti, Sébastien Rinaldetti, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martine Jotterand, Alois Gratwohl, Axel R. Zander, Professor, Nicolaus Kröger, Dietrich W. Beelen, MD, Jürgen Novotny, Christoph Nerl, Christof Scheid, MD PhD, Karsten Spiekermann, Jiri Mayer, MD, Herbert G. Sayer, Christiane Falge, Donald Bunjes, MD, Hartmut Döhner, Prof. Dr., Arnold Ganser, Peter Brossart, MD, Rainer Schwerdtfeger, Herrad Baumann, Rolf Kuse, Hans Walter Lindemann, MD, Matthias Bormann, Bernd Hertenstein, MD, Gabriela M. Baerlocher, Carlo Aul, MD, Peter Staib, Matthias Edinger, MD, Michael Schatz, Axel A Fauser, Renate Arnold, MD, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, Susanne Schnittger, PhD, Martin C. Müller, MD, Andreas Reiter, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Joerg Hasford, Michele Baccarani, Ruediger Hehlmann, MD

Blood (2015) 126 (23): 1581.

https://doi.org/10.1182/blood.V126.23.1581.1581

Published: 2015

Journal Articles

Graft-Versus-Host Disease Impairs Early B Lymphopoiesis in the Bone Marrow

Kristina Doser, PhD, Tina J Boeld, PhD, Martin Heidenreich, Reinhard Andreesen, MD, PhD, Petra Hoffmann, PhD, Matthias Edinger, MD

Blood (2011) 118 (21): 2976.

https://doi.org/10.1182/blood.V118.21.2976.2976

Published: 2011

Journal Articles

Increased Susceptibility to Fungal Infection in Recipients with GVHD Is Not Due to Impaired Pathogen Clearance and Can Be Prevented by Co-Transfer of Donor CD4 + CD25 + Regulatory T Cells

Petra Hoffmann, PhD, Kristina Doser, PhD, Matthias Edinger, MD, Bernd Echtenacher, PhD

Blood (2011) 118 (21): 822.

https://doi.org/10.1182/blood.V118.21.822.822

Published: 2011

Journal Articles

Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4 + CD25 + Regulatory T Cells

Tina J Boeld, PhD, Kristina Doser, PhD, Corinna Lang-Schwarz, MD, Elisabeth Huber, MD, Reinhard Andreesen, MD, PhD, Petra Hoffmann, PhD, Matthias Edinger, MD

Blood (2011) 118 (21): 2987.

https://doi.org/10.1182/blood.V118.21.2987.2987

Published: 2011

Journal Articles

Delayed Onset of T Cell-Mediated Xenogeneic Disease in Rag2 −/− γ c −/− mice after Co- Transplantation of in Vitro Expanded Human CD4 + CD25 high CD45RA + Regulatory T Cells

Tina J Boeld, Ellen Obermann, Reinhard Andreesen, Petra Hoffmann, Matthias Edinger, MD

Blood (2008) 112 (11): 4609.

https://doi.org/10.1182/blood.V112.11.4609.4609

Published: 2008

Journal Articles

Loss of FOXP3 Expression and Emergence of Cytokine-Producing Cells after In Vitro Expansion of Human CD4+CD25+CD127 - Regulatory T Cells.

Petra Hoffmann, PhD, Ruediger Eder, Tina J. Boeld, Jochen Huehn, PhD, Stefan Floess, PhD, Georg Wieczorek, PhD, Udo Baron, PhD, Sven Olek, PhD, Reinhard Andreesen, MD, Matthias Edinger, MD

Blood (2007) 110 (11): 63.

https://doi.org/10.1182/blood.V110.11.63.63

Published: 2007

Journal Articles

Low-Dose Cyclosporin A Does Not Abrogate the Suppressive Function of In Vitro Expanded Human CD4 + CD25 + Regulatory T Cells.

Biserka Piseshka, Ruediger Eder, Tina J. Boeld, Reinhard Andreesen, MD, Ernst Holler, MD, Petra Hoffmann, PhD, Matthias Edinger, MD

Blood (2006) 108 (11): 5170.

https://doi.org/10.1182/blood.V108.11.5170.5170

Published: 2006

Journal Articles

Only Naive CD45RA + CD4 + CD25 high T Cells from Human Peripheral Blood Give Rise to Homogeneous Regulatory T Cell Lines.

Petra Hoffmann, PhD, Ruediger Eder, Tina J. Boeld, Kristina Doser, Biserka Piseshka, Reinhard Andreesen, MD, Matthias Edinger, MD

Blood (2006) 108 (11): 3163.

https://doi.org/10.1182/blood.V108.11.3163.3163

Published: 2006

Journal Articles

Isolation of Human CD4 + CD25 + T Cells with Regulatory Capacity for Clinical Trials.

Petra Hoffmann, PhD, Ruediger Eder, Biserka Piseshka, Andrea Havasi, Evelyn Orso, MD, Ashraf Dada, MD, Reinhard Andreesen, MD, Ernst Holler, MD, Matthias Edinger, MD

Blood (2004) 104 (11): 2851.

https://doi.org/10.1182/blood.V104.11.2851.2851

Published: 2004

Journal Articles

Inhibitory Effects of Lactic Acid on Human Antigen-Specific CD8+ T-Cells.

Marina Kreutz, PhD, Karin Fischer, PhD, Petra Hoffmann, PhD, Simon Volkl, Matthias Edinger, MD, Reinhard Andreesen, MD, Andreas Mackensen, PhD

Blood (2004) 104 (11): 3844.

https://doi.org/10.1182/blood.V104.11.3844.3844

Published: 2004

NARROW

Profiling T Cell Receptor Repertoires in Phase I/II Clinical Trials of Donor Treg Infusion for the Treatment of Chronic Graft-Versus-Host Disease

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

Assessment of Calcineurin Inhibitor-Associated Neurotoxicity in Patients with Sickle Cell Disease Receiving a Matched Sibling Donor or T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Comparable Outcome of CD3+-/CD19+ Depleted Haploidentical with Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Advanced Stage Sickle Cell Disease: Result of a Pilot Study

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Graft-Versus-Host Disease Impairs Early B Lymphopoiesis in the Bone Marrow

Increased Susceptibility to Fungal Infection in Recipients with GVHD Is Not Due to Impaired Pathogen Clearance and Can Be Prevented by Co-Transfer of Donor CD4 + CD25 + Regulatory T Cells

Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4 + CD25 + Regulatory T Cells

Delayed Onset of T Cell-Mediated Xenogeneic Disease in Rag2 −/− γ c −/− mice after Co- Transplantation of in Vitro Expanded Human CD4 + CD25 high CD45RA + Regulatory T Cells

Loss of FOXP3 Expression and Emergence of Cytokine-Producing Cells after In Vitro Expansion of Human CD4+CD25+CD127 - Regulatory T Cells.

Low-Dose Cyclosporin A Does Not Abrogate the Suppressive Function of In Vitro Expanded Human CD4 + CD25 + Regulatory T Cells.

Only Naive CD45RA + CD4 + CD25 high T Cells from Human Peripheral Blood Give Rise to Homogeneous Regulatory T Cell Lines.

Isolation of Human CD4 + CD25 + T Cells with Regulatory Capacity for Clinical Trials.

Inhibitory Effects of Lactic Acid on Human Antigen-Specific CD8+ T-Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only